Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Oas1e Activators

Oas1e, an interferon (IFN)-inducible protein, plays a significant role in cellular responses to viral infections. Its activity is intricately linked to the IFN signaling pathway and can be modulated by compounds that influence this pathway. Epigallocatechin Gallate (EGCG) and Curcumin, for instance, exert their effects on Oas1e by modulating the NF-κB and JAK/STAT pathways, respectively. EGCG activates NF-κB, a pivotal factor in enhancing IFN-induced gene expression, thereby indirectly boosting Oas1e activity. Curcumin, on the other hand, activates the JAK/STAT pathway, crucial for IFN signal transduction, thereby facilitating Oas1e's functional upregulation. Similarly, Resveratrol and Sulforaphane enhance Oas1e activity through SIRT1 and Nrf2 pathways, respectively, both of which augment IFN signaling. This enhancement of IFN signaling, in turn, promotes the activity of Oas1e. Additionally, TPCA-1 and Piperlongumine influence Oas1e indirectly; TPCA-1 by modulating NF-κB activity through IKK-2 inhibition and Piperlongumine by increasing ROS levels, affecting NF-κB and STAT pathways.

The activity of Oas1e is also modulated by compounds that indirectly influence the IFN signaling pathway through various mechanisms. JQ1, a BET bromodomain inhibitor, enhances IFN signaling by inhibiting negative regulators, thereby indirectly increasing Oas1e activity. Quercetin and Ruxolitinib play roles in modulating the STAT component of the JAK/STAT pathway, with Quercetin enhancing STAT1 activity and Ruxolitinib paradoxically increasing cell sensitivity to IFN signals. Stattic's selective inhibition of STAT3 leads to a compensatory upregulation of STAT1, enhancing IFN signaling and thus Oas1e activity. Furthermore, Palbociclib and Andrographolide indirectly augment Oas1e activity; Palbociclib by affecting cell cycle-related signals that intersect with IFN signaling, and Andrographolide by activating transcription factors within the IFN pathway. Collectively, these compounds enhance Oas1e's role in the IFN signaling pathway, demonstrating a diverse yet interconnected network of biochemical pathways that converge to regulate this crucial protein.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Activates NF-κB signaling, indirectly enhancing Oas1e by upregulating IFN-inducible genes.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

BET bromodomain inhibitor that indirectly enhances Oas1e by inhibiting negative regulators of IFN pathway.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Activates SIRT1, positively regulating the IFN signaling pathway and indirectly promoting Oas1e activity.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Activates the JAK/STAT pathway, indirectly increasing Oas1e activity through enhanced IFN signaling.

IKK-2 Inhibitor IV

507475-17-4sc-203083
500 µg
$133.00
12
(1)

An IKK-2 inhibitor that modulates NF-κB activity, indirectly enhancing IFN signaling and upregulating Oas1e.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Activates Nrf2, indirectly promoting Oas1e activity by upregulating IFN-stimulated genes.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Enhances STAT1 activity in the JAK/STAT pathway, promoting Oas1e function through increased IFN signaling.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

JAK inhibitor that paradoxically enhances cell sensitivity to IFN signals, indirectly enhancing Oas1e activity.

Stat3 inhibitor V, stattic

19983-44-9sc-202818
sc-202818A
sc-202818B
sc-202818C
sc-202818D
sc-202818E
sc-202818F
25 mg
100 mg
250 mg
500 mg
1 g
2.5 g
5 g
$130.00
$196.00
$274.00
$512.00
$731.00
$1408.00
$2091.00
114
(3)

Selectively inhibits STAT3, leading to compensatory upregulation of STAT1 and enhanced IFN signaling, indirectly upregulating Oas1e.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

A CDK4/6 inhibitor that indirectly enhances Oas1e activity by modulating cell cycle-related signals intersecting with IFN signaling pathways.